Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Constant Therapy: Brain+Speech

Constant Therapy: Brain+Speech

By Constant Therapy

Constant Therapy is a medical app providing AI-guided speech and cognitive therapy for neurological recovery on iOS and Android.

The App DNA

What makes this app unique?

Users hire the app to bridge the gap between infrequent clinical visits with daily, evidence-based exercises that track recovery progress.

For Patients recovering from stroke, TBI, or living with neurological conditions like aphasia and dementia, and the clinicians who treat them.

What does it look like?

Key features

NeuroPerformance Engine (NPE)edge

AI-driven algorithm that adapts exercise difficulty based on individual patient progress.

Clinician Portaledge

Remote monitoring dashboard for speech-language pathologists to track patient performance.

Evidence-Based Exercise Libraryedge

1 million+ exercises across 90+ therapy areas validated by 70+ clinical studies.

How much does it cost?

subscriptionFree 14-day trialSubscription-based access for patients and clinicians

Subscription model anchored in clinical efficacy, targeting both individual patients and clinical institutions to maximize recurring revenue.

Velocity

Intense developmentShow more...

5 versions in history. Development pace: intense.

See all version history

Who built it?

Constant Therapy

2 apps tracked · Medical

Constant Therapy ClinicianConstant Therapy Clinician
Explore the full publisher profile

User Sentiment

What do users think recently?

Recent user voice shows an excited sentiment. Users appreciate personalized therapy exercises provide measurable cognitive recovery for stroke and brain injury survivors.

How are ratings & reviews evolving?

App Store
4.50 · 3k
Google Play
4.58 · 1k

What users say, by theme

What Users Love
  • Personalized therapy exercises provide measurable cognitive recovery for stroke and brain injury survivors
What Frustrates Users
  • Subscription cancellation and free trial transition processes create significant friction for new users
What Users Want 1 request inside

49 of 49 recent reviews analyzed · high confidence · Excited overall

Read the full review analysis

Unlock 1 user request, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for Constant Therapy: Brain+Speech

How's the Medical market?

Constant Therapy maintains a presence in the Health & Fitness category, ranking #52 Grossing in the US and #197 Grossing in the US Health & Fitness chart. The disparity between free-user acquisition and grossing rank indicates that monetization friction is limiting the conversion of the 800,000-user base.

Read the market outlook

The rivals identified

BrainHQ
BrainHQactive nemesis

By Posit Science

Directly competes in the clinical-grade cognitive training space with a focus on neuroplasticity and evidence-based exercises.

  • Focuses on intensive, scientifically-validated neuroplasticity exercises rather than general speech or language therapy activities.
  • Utilizes a subscription-based model for full access, contrasting with this app's broader, multi-condition clinical focus.
Constant Therapy: Brain+Speech vs BrainHQ

Unlock the deeper market read.

Access the full report for free

The Analyst's Read

Key takeaways for Constant Therapy: Brain+Speech

Where is it heading?

The digital therapeutics market is shifting toward sensor-based, automated clinical care, leaving screen-only therapy apps like Constant Therapy exposed to disruption. The app must pivot from a static exercise library to a more accessible, adaptive experience to maintain its clinical-grade status against AI-driven rivals.

  • Subscription cancellation friction in the latest release drives churn, which compounds the rating drag already visible on Android.
  • Expanded language support in the latest release signals active investment in international B2B distribution, not maintenance mode.

The SWOT

Core Strengths
  • NeuroPerformance Engine functions as a clinical-grade moat, justifying subscription pricing over generic brain-training apps.
  • Clinician Portal integrates the app into clinical workflows, driving institutional adoption and patient referrals.
  • Clinical validation across 70+ studies supports premium positioning and acts as a barrier to entry.
Critical Frictions 3 weaknesses inside
Growth Levers
  • Adjustable pacing controls would improve accessibility for the geriatric population and those with slower cognitive processing.
  • UI legibility updates for older users would reduce churn among the core patient demographic.
  • International expansion via multi-language support provides a B2B distribution path into global clinical partnerships.
Market Threats 3 threats identified

Next best moves

1 Pivot · 1 Invest

Audit subscription cancellation flow because it is the top-cited complaint → reduce refund surge and negative sentiment.

+ 1 more prioritized move

The counter-intuitive read

The app's reliance on a subscription model for clinical recovery is a vulnerability…

Read the full take

Feature gaps

Real-time motion tracking (available in Sword Health but absent here) +1

Since the last report: The platform has pivoted to a subscription-first clinical model, resulting in increased competitive differentiation but higher user friction regarding billing and cancellation.

Bottom line

Constant Therapy succeeds as a clinical-grade tool, but its monetization friction threatens long-term retention, so the PM must prioritize simplifying the cancellation flow to protect the user base from churn.

Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Constant Therapy: Brain+Speech, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The platform has pivoted to a subscription-first clinical model, resulting in increased competitive differentiation but higher user friction regarding billing and cancellation.

shifted

Subscription-first model

shifted

Clinical-grade positioning

declined

Subscription cancellation friction

improved

Feature repositioning

Cite this report

Marlvel.ai. “Constant Therapy: Brain+Speech Intelligence Report.” Updated Jun 21, 2026. https://marlvel.ai/apps/com-constant-therapy-therapy

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0